Explain the mechanism of acute respiratory distress syndrome

Reading File

Finding Sources

Searching PubMed

"acute respiratory distress syndrome"[MeSH Terms] AND pathophysiology

Reading File

Finding Sources

Reading File

Loading Image

Searching Images

ARDS acute respiratory distress syndrome pathophysiology diffuse alveolar damage mechanism diagram

Loading Image

I now have all the material needed for a thorough, well-illustrated answer. Here is the comprehensive explanation:

Acute Respiratory Distress Syndrome (ARDS): Mechanism

Definition and Overview

ARDS is a syndrome of noncardiogenic pulmonary edema characterized by severe lung inflammation, diffuse alveolar damage (DAD), hypoxemia, and reduced lung compliance leading to respiratory failure. Unlike cardiogenic pulmonary edema (caused by elevated hydrostatic pressures), the edema in ARDS is exudative — the alveolar-capillary barrier breaks down and protein-rich fluid leaks into the airspaces.

"In ARDS, the edema fluid that fills the alveoli is exudative. In other words, the alveolar-capillary barrier exhibits increased permeability, allowing for the leakage of protein-rich fluid into the airspaces." — Murray & Nadel's Textbook of Respiratory Medicine

Triggers: Direct vs. Indirect Injury

Direct (Pulmonary)	Indirect (Nonpulmonary)
Pneumonia (bacterial, viral, COVID-19)	Sepsis
Aspiration	Major trauma
Pulmonary contusion	Multiple blood transfusions
Toxic inhalation / near-drowning	Pancreatitis, cardiopulmonary bypass
Reperfusion injury (post-transplant)	Drug overdose

Whether the trigger is pulmonary or nonpulmonary, the downstream lung pathology is indistinguishable.

Core Pathophysiological Mechanisms

1. Alveolar-Capillary Barrier Disruption

The alveolar-capillary unit has two cellular layers that normally keep the alveoli dry:

Pulmonary microvascular endothelium (capillary side)
Alveolar epithelium — type I pneumocytes (gas exchange, ~95% of surface area) and type II pneumocytes (surfactant production, progenitor cells)

In ARDS, both layers are injured. Type I pneumocyte destruction is particularly critical because these cells are largely non-regenerative. Type II pneumocyte injury impairs surfactant production, further collapsing alveoli.

The result: loss of the fluid exclusion barrier → protein-rich fluid, fibrin, and cellular debris flood the alveolar space.

2. Neutrophil-Mediated Injury (Central Mechanism)

Neutrophils are recruited in massive numbers from the pulmonary microvasculature into the alveolar space and are the primary effectors of DAD. They cause injury via:

Reactive oxygen species (ROS) — oxidative damage to lipid membranes and proteins
Proteases (elastase, matrix metalloproteinases) — degrade the extracellular matrix and tight junction proteins
Neutrophil extracellular traps (NETs) — chromatin + enzymes that amplify inflammation and activate complement and coagulation
Myeloperoxidase (MPO) — generates hypochlorous acid, further damaging epithelium

Neutrophil recruitment is driven by chemokines (particularly IL-8/CXCL8) and platelet-activating factor (PAF) released from activated alveolar macrophages and endothelial cells.

3. The Cytokine Storm

Alveolar macrophages (the first-line responders) detect danger signals via TLR/PRR pathways and release a cascade of pro-inflammatory mediators:

Mediator	Role
TNF-α, IL-1β	Activate endothelium, increase adhesion molecules (ICAM-1, E-selectin), recruit neutrophils
IL-6	Amplifies inflammation; elevated levels predict mortality
IL-8 (CXCL8)	Primary neutrophil chemoattractant into the lung
IL-17	Released by Th17 cells; amplifies neutrophilic inflammation
Prostaglandins, leukotrienes	Increase vascular permeability
Complement fragments (C3a, C5a)	Further recruit and activate neutrophils; increase permeability
Angiopoietin-2 (Ang-2)	Destabilizes endothelial junctions; elevated Ang-2 predicts mortality

The T-regulatory cell population is simultaneously suppressed, removing a key brake on the inflammatory response.

4. Endothelial and Epithelial Tight Junction Breakdown

Cytokines and proteases disrupt intercellular tight junctions (occludin, claudins, VE-cadherin on endothelial cells), causing a loss of paracellular barrier function. Fluid, plasma proteins, and leukocytes pour from capillaries into the interstitium and then into alveoli. This is fundamentally different from hydrostatic edema — the protein content of the edema fluid is nearly equal to plasma.

5. Surfactant Dysfunction

Type II pneumocyte destruction reduces surfactant synthesis
Plasma proteins (especially fibrinogen) that flood the alveoli inactivate existing surfactant
Phospholipase A2 (released during pancreatitis or systemic inflammation) directly degrades surfactant phospholipids

Without surfactant, alveolar surface tension rises dramatically → alveolar collapse (atelectasis) and severely reduced lung compliance ("stiff lungs").

6. Coagulation Dysregulation

The injured alveolar microenvironment activates the coagulation cascade:

Fibrin deposition in alveoli contributes to hyaline membrane formation
Microvascular thrombosis reduces capillary perfusion
Simultaneous impairment of fibrinolysis (through elevated PAI-1) prevents clot resolution
This creates a procoagulant, antifibrinolytic environment within the lung

7. Pulmonary Hypertension

Multiple mechanisms contribute to elevated pulmonary artery pressure in ARDS:

Hypoxic pulmonary vasoconstriction (the Euler-Liljestrand reflex, usually protective, becomes maladaptive when widespread)
Intravascular fibrin/thrombus obstructing pulmonary arterioles
External compression of vessels by positive-pressure ventilation
Mediator-driven vasoconstriction (thromboxane A2, ET-1)

The Three Histopathological Phases

CT scan and histology of diffuse alveolar damage in ARDS: CT shows bilateral ground-glass opacities (left); H&E biopsy shows hyaline membranes and thickened alveolar walls (right)

Phase 1: Exudative (Days 1–7)

Protein-rich edema fluid, fibrin, and neutrophils flood the alveoli
Hyaline membrane formation (cellular debris + fibrin lining the alveolar walls) — the histological hallmark
Widespread type I pneumocyte necrosis
Interstitial infiltration with neutrophils
Clinical: severe hypoxemia, bilateral infiltrates on imaging

Phase 2: Proliferative (Days 7–21)

Type II pneumocytes proliferate to cover denuded alveolar walls (attempting repair)
Organization of hyaline membranes
Early fibroblast infiltration → early fibrosis
Decline in neutrophils
Some patients improve; others progress

Phase 3: Fibrotic (>21 days)

Progressive pulmonary fibrosis in a subset of patients
Obliteration of alveolar spaces and pulmonary capillaries
Collagen deposition in alveoli and interstitium
Elevated N-terminal procollagen peptide III in BAL fluid can be detected as early as 24 hours, indicating early fibrogenesis
Associated with prolonged mechanical ventilation and worse prognosis

Physiological Consequences

Consequence	Mechanism
Severe hypoxemia (refractory)	Right-to-left shunt through fluid/collapsed alveoli; no response to supplemental O₂ alone
Reduced lung compliance	Alveolar flooding, atelectasis, surfactant loss → "stiff lungs"
Increased dead space	Microvascular occlusion → ventilated but unperfused alveoli → ↑ minute ventilation required
Pulmonary hypertension	Vasoconstriction, microvascular thrombosis, compression
Multiorgan dysfunction	Cytokine spillover into systemic circulation; ventilator-induced lung injury further amplifies mediator release (biotrauma)

Ventilator-Induced Lung Injury (VILI) — A Secondary Mechanism

Mechanical ventilation can cause both biochemical injury (biotrauma via cytokines, complement, ROS, proteases released from macrophages and neutrophils) and biophysical injury (shear, overdistention, cyclic stretch) — leading to increased alveolar-capillary permeability and worsened organ dysfunction

Mechanical ventilation itself worsens ARDS through:

Volutrauma/barotrauma: Overdistension of remaining aerated alveoli
Atelectrauma: Repetitive collapse-reopening cycles at end-expiration
Biotrauma: Mechanical stretch activates lung macrophages and epithelial cells, triggering further cytokine release that spills systemically — contributing to multiorgan failure

This is the physiological rationale for lung-protective ventilation (low tidal volumes 6 mL/kg predicted body weight, plateau pressure <30 cmH₂O).

Summary Cascade

Triggering insult (sepsis, pneumonia, trauma, aspiration...)
        ↓
Alveolar macrophage activation → TLR/PRR signaling
        ↓
Cytokine storm (TNF-α, IL-1β, IL-6, IL-8, complement)
        ↓
Endothelial activation → neutrophil adhesion & transmigration
        ↓
Neutrophil-mediated injury (ROS, proteases, NETs, MPO)
        ↓
Alveolar-capillary barrier breakdown
        ↓
Protein-rich exudative edema floods alveoli
        ↓
Surfactant inactivation + alveolar collapse
        ↓
Hyaline membrane formation (DAD) + coagulation activation
        ↓
Hypoxemia, reduced compliance, pulmonary hypertension
        ↓
ARDS → potential fibrosis → multiorgan dysfunction

Sources:

Murray & Nadel's Textbook of Respiratory Medicine, Chapter 134 (Pathogenesis and Pathology of ARDS)
Goldman-Cecil Medicine, Chapter 91 (ARDS and Mechanical Ventilation)
Goldman-Cecil Medicine, Chapter 90

This is a shared conversation. Sign in to Orris to start your own chat.